JPWO2006004214A1 - リン酸化タンパク質のプロテオーム解析方法 - Google Patents
リン酸化タンパク質のプロテオーム解析方法 Download PDFInfo
- Publication number
- JPWO2006004214A1 JPWO2006004214A1 JP2006529017A JP2006529017A JPWO2006004214A1 JP WO2006004214 A1 JPWO2006004214 A1 JP WO2006004214A1 JP 2006529017 A JP2006529017 A JP 2006529017A JP 2006529017 A JP2006529017 A JP 2006529017A JP WO2006004214 A1 JPWO2006004214 A1 JP WO2006004214A1
- Authority
- JP
- Japan
- Prior art keywords
- protein
- sample
- phosphorylated
- proteins
- database
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091005981 phosphorylated proteins Proteins 0.000 title claims abstract description 192
- 238000004458 analytical method Methods 0.000 title claims description 25
- 108010026552 Proteome Proteins 0.000 title description 8
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 237
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 237
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 213
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 133
- 238000000034 method Methods 0.000 claims abstract description 129
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 93
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 46
- 239000002253 acid Substances 0.000 claims description 46
- 239000013060 biological fluid Substances 0.000 claims description 22
- 210000000056 organ Anatomy 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 20
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 19
- -1 iron ion Chemical class 0.000 claims description 17
- 238000001742 protein purification Methods 0.000 claims description 17
- 229910052742 iron Inorganic materials 0.000 claims description 13
- 238000004949 mass spectrometry Methods 0.000 claims description 13
- 238000011067 equilibration Methods 0.000 claims description 5
- CKHJYUSOUQDYEN-UHFFFAOYSA-N gallium(3+) Chemical compound [Ga+3] CKHJYUSOUQDYEN-UHFFFAOYSA-N 0.000 claims description 5
- 229910021645 metal ion Inorganic materials 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 4
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 abstract description 16
- 239000002184 metal Substances 0.000 abstract description 16
- 239000000243 solution Substances 0.000 description 106
- 239000000523 sample Substances 0.000 description 105
- 210000004027 cell Anatomy 0.000 description 61
- 235000010215 titanium dioxide Nutrition 0.000 description 59
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 48
- 238000000746 purification Methods 0.000 description 42
- 108090000765 processed proteins & peptides Proteins 0.000 description 39
- 150000001413 amino acids Chemical class 0.000 description 32
- 238000005259 measurement Methods 0.000 description 26
- 108090000631 Trypsin Proteins 0.000 description 24
- 102000004142 Trypsin Human genes 0.000 description 24
- 239000012588 trypsin Substances 0.000 description 24
- 102100021935 C-C motif chemokine 26 Human genes 0.000 description 23
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 23
- 210000001519 tissue Anatomy 0.000 description 22
- 238000005119 centrifugation Methods 0.000 description 19
- 239000006228 supernatant Substances 0.000 description 19
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 16
- 239000012488 sample solution Substances 0.000 description 16
- 238000005194 fractionation Methods 0.000 description 15
- 102000004196 processed proteins & peptides Human genes 0.000 description 15
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 14
- 235000011114 ammonium hydroxide Nutrition 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 230000026731 phosphorylation Effects 0.000 description 14
- 238000006366 phosphorylation reaction Methods 0.000 description 14
- 238000001179 sorption measurement Methods 0.000 description 14
- 238000001514 detection method Methods 0.000 description 13
- 238000010828 elution Methods 0.000 description 13
- 239000011159 matrix material Substances 0.000 description 13
- 230000029087 digestion Effects 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 12
- 239000000499 gel Substances 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 10
- 229930006000 Sucrose Natural products 0.000 description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 239000005720 sucrose Substances 0.000 description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 9
- 238000003776 cleavage reaction Methods 0.000 description 9
- 238000005886 esterification reaction Methods 0.000 description 9
- 230000007017 scission Effects 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- 238000002331 protein detection Methods 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 7
- 230000002378 acidificating effect Effects 0.000 description 7
- 238000001042 affinity chromatography Methods 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- 238000000132 electrospray ionisation Methods 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 108010001441 Phosphopeptides Proteins 0.000 description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 6
- 238000001976 enzyme digestion Methods 0.000 description 6
- 230000032050 esterification Effects 0.000 description 6
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical group OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 6
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 108010058846 Ovalbumin Proteins 0.000 description 5
- 239000004809 Teflon Substances 0.000 description 5
- 229920006362 Teflon® Polymers 0.000 description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- RVTGFZGNOSKUDA-ZNGNCRBCSA-N cyclohexyl-pentyl-maltoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@@H](OCCCCCC2CCCCC2)[C@H](O)[C@H]1O RVTGFZGNOSKUDA-ZNGNCRBCSA-N 0.000 description 5
- 238000003795 desorption Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 5
- 229940092253 ovalbumin Drugs 0.000 description 5
- 230000004481 post-translational protein modification Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 108010089430 Phosphoproteins Proteins 0.000 description 4
- 102000007982 Phosphoproteins Human genes 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 238000005571 anion exchange chromatography Methods 0.000 description 4
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 description 4
- 238000005277 cation exchange chromatography Methods 0.000 description 4
- 238000000451 chemical ionisation Methods 0.000 description 4
- 238000000432 density-gradient centrifugation Methods 0.000 description 4
- 239000012470 diluted sample Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000010265 fast atom bombardment Methods 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 3
- 238000005349 anion exchange Methods 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- 238000005341 cation exchange Methods 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229910052733 gallium Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 238000001114 immunoprecipitation Methods 0.000 description 3
- 238000005040 ion trap Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 description 3
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000007086 side reaction Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- AFVLVVWMAFSXCK-UHFFFAOYSA-N α-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(C#N)=CC1=CC=C(O)C=C1 AFVLVVWMAFSXCK-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 101001018085 Lysobacter enzymogenes Lysyl endopeptidase Proteins 0.000 description 2
- 108010085220 Multiprotein Complexes Proteins 0.000 description 2
- 102000007474 Multiprotein Complexes Human genes 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 238000002144 chemical decomposition reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 229960002376 chymotrypsin Drugs 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000011033 desalting Methods 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- 230000006862 enzymatic digestion Effects 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 210000003016 hypothalamus Anatomy 0.000 description 2
- 238000000752 ionisation method Methods 0.000 description 2
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000009822 protein phosphorylation Effects 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102100034612 Annexin A4 Human genes 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 108010034715 Light-Harvesting Protein Complexes Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000004485 Nijmegen breakage syndrome Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 241000219315 Spinacia Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 241000269368 Xenopus laevis Species 0.000 description 1
- 102000007624 ZAP-70 Protein-Tyrosine Kinase Human genes 0.000 description 1
- 108010046882 ZAP-70 Protein-Tyrosine Kinase Proteins 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 210000004727 amygdala Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000017455 cell-cell adhesion Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003793 centrosome Anatomy 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- XOYLJNJLGBYDTH-UHFFFAOYSA-M chlorogallium Chemical compound [Ga]Cl XOYLJNJLGBYDTH-UHFFFAOYSA-M 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- UPWPDUACHOATKO-UHFFFAOYSA-K gallium trichloride Chemical compound Cl[Ga](Cl)Cl UPWPDUACHOATKO-UHFFFAOYSA-K 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000004216 mammary stem cell Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 210000003593 megakaryocyte Anatomy 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 108091005601 modified peptides Proteins 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical group OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 210000000956 olfactory bulb Anatomy 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000012509 protein identification method Methods 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 238000000575 proteomic method Methods 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000028617 response to DNA damage stimulus Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 210000003935 rough endoplasmic reticulum Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 210000001908 sarcoplasmic reticulum Anatomy 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000783 smooth endoplasmic reticulum Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 210000003670 sublingual gland Anatomy 0.000 description 1
- 210000001913 submandibular gland Anatomy 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 210000003568 synaptosome Anatomy 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8675—Evaluation, i.e. decoding of the signal into analytical information
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/54—Sorbents specially adapted for analytical or investigative chromatography
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Library & Information Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004197344 | 2004-07-02 | ||
| JP2004197344 | 2004-07-02 | ||
| PCT/JP2005/012714 WO2006004214A1 (ja) | 2004-07-02 | 2005-07-04 | リン酸化タンパク質のプロテオーム解析方法 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010017929A Division JP2010133971A (ja) | 2004-07-02 | 2010-01-29 | リン酸化タンパク質のプロテオーム解析方法 |
| JP2010291592A Division JP2011090012A (ja) | 2004-07-02 | 2010-12-28 | リン酸化タンパク質のプロテオーム解析方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2006004214A1 true JPWO2006004214A1 (ja) | 2008-04-24 |
Family
ID=35783007
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006529017A Pending JPWO2006004214A1 (ja) | 2004-07-02 | 2005-07-04 | リン酸化タンパク質のプロテオーム解析方法 |
| JP2010017929A Withdrawn JP2010133971A (ja) | 2004-07-02 | 2010-01-29 | リン酸化タンパク質のプロテオーム解析方法 |
| JP2010291592A Withdrawn JP2011090012A (ja) | 2004-07-02 | 2010-12-28 | リン酸化タンパク質のプロテオーム解析方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010017929A Withdrawn JP2010133971A (ja) | 2004-07-02 | 2010-01-29 | リン酸化タンパク質のプロテオーム解析方法 |
| JP2010291592A Withdrawn JP2011090012A (ja) | 2004-07-02 | 2010-12-28 | リン酸化タンパク質のプロテオーム解析方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8131479B2 (https=) |
| EP (2) | EP2113562B1 (https=) |
| JP (3) | JPWO2006004214A1 (https=) |
| AT (2) | ATE545460T1 (https=) |
| WO (1) | WO2006004214A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012524252A (ja) * | 2009-04-17 | 2012-10-11 | クイーン マリー アンド ウエストフィールド カレッジ | 修飾ペプチドの定量化方法 |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100855620B1 (ko) | 2005-12-13 | 2008-09-03 | 주식회사 프로바이온 | 메조다공성 이산화티탄을 이용한 분리 또는 농축방법 |
| WO2008148645A1 (en) * | 2007-06-07 | 2008-12-11 | Syddansk Universitet | Separation of mono- from multi-phoshorylated peptides |
| WO2009102258A1 (en) * | 2008-02-15 | 2009-08-20 | Ge Healthcare Bio-Sciences Ab | Separation of biomolecules |
| JP5181908B2 (ja) * | 2008-08-04 | 2013-04-10 | 株式会社島津製作所 | 質量分析データ解析装置 |
| EP2588428A4 (en) * | 2010-06-30 | 2014-03-05 | Univ Saskatchewan | Kinome ANALYSIS PROCEDURE |
| GB201017721D0 (en) * | 2010-10-20 | 2010-12-01 | Queen Mary & Westfield College | Method |
| US9659146B2 (en) | 2011-05-02 | 2017-05-23 | Tyler Stuart Bray | Method for quantitative analysis of complex proteomic data |
| JP5776443B2 (ja) * | 2011-08-29 | 2015-09-09 | 株式会社島津製作所 | 質量分析を用いた修飾タンパク質同定方法及び同定装置 |
| GB201204278D0 (en) | 2012-03-09 | 2012-04-25 | Queen Mary & Westfield College | Method |
| GB201520178D0 (en) | 2015-11-16 | 2015-12-30 | Univ London Queen Mary | Method |
| CN108287200B (zh) * | 2017-04-24 | 2020-12-18 | 麦特绘谱生物科技（上海）有限公司 | 质谱参照数据库的建立方法及基于其的物质分析方法 |
| JP6928816B2 (ja) * | 2017-12-14 | 2021-09-01 | 株式会社Ｌｓｉメディエンス | 質量分析計を用いたタンパク質分析のためのタンパク質含有試料の前処理方法 |
| CN108872442B (zh) * | 2018-08-17 | 2021-04-27 | 无限极（中国）有限公司 | 一种基于谱效关系的骨胶原肽质量检测方法 |
| AU2020288652A1 (en) * | 2019-06-05 | 2021-11-18 | Amgen Inc. | Methods of identifying attributes of therapeutic proteins |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002072863A2 (en) * | 2001-03-09 | 2002-09-19 | Applera Corporation | Methods for large scale protein matching |
| JP2003521257A (ja) * | 2000-02-07 | 2003-07-15 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | （ポリ）ペプチドを同定しおよび／または特性決定するための方法 |
| WO2003065031A1 (en) * | 2002-01-31 | 2003-08-07 | Gl Sciences Incorporated | Method and apparatus for analyzing amino acid, peptide, protein, saccharide or lipid |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5674987A (en) | 1994-07-22 | 1997-10-07 | Anatrace, Inc. | Extraction of proteins from naturally occurring membranes |
| US7063966B2 (en) | 2001-07-11 | 2006-06-20 | Sri International | Chimeric G protein coupled receptors |
| US7026167B2 (en) * | 2001-12-28 | 2006-04-11 | University Of Virginia Patent Foundation | Systems and methods for the analysis of protein phosphorylation |
-
2005
- 2005-07-04 AT AT09009136T patent/ATE545460T1/de active
- 2005-07-04 JP JP2006529017A patent/JPWO2006004214A1/ja active Pending
- 2005-07-04 EP EP09009136A patent/EP2113562B1/en not_active Expired - Lifetime
- 2005-07-04 EP EP05758169A patent/EP1780537B1/en not_active Expired - Lifetime
- 2005-07-04 AT AT05758169T patent/ATE525462T1/de not_active IP Right Cessation
- 2005-07-04 WO PCT/JP2005/012714 patent/WO2006004214A1/ja not_active Ceased
- 2005-07-04 US US11/630,927 patent/US8131479B2/en not_active Expired - Fee Related
-
2010
- 2010-01-29 JP JP2010017929A patent/JP2010133971A/ja not_active Withdrawn
- 2010-12-28 JP JP2010291592A patent/JP2011090012A/ja not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003521257A (ja) * | 2000-02-07 | 2003-07-15 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | （ポリ）ペプチドを同定しおよび／または特性決定するための方法 |
| WO2002072863A2 (en) * | 2001-03-09 | 2002-09-19 | Applera Corporation | Methods for large scale protein matching |
| WO2003065031A1 (en) * | 2002-01-31 | 2003-08-07 | Gl Sciences Incorporated | Method and apparatus for analyzing amino acid, peptide, protein, saccharide or lipid |
Non-Patent Citations (3)
| Title |
|---|
| JPN6009061312, 小田吉哉, ""リン酸化プロテオーム解析の最新技術"", 実験医学, 2002, Ｖｏｌ．２０， Ｎｏ．１, ｐ．２３−２７ * |
| JPN6009061315, 平野久，外１名, ""タンパク質の翻訳後修飾の解析"", 実験医学, 2002, Ｖｏｌ．２０， Ｎｏ．１４, ｐ．４５−５０ * |
| JPN6009061318, 小田吉哉, ""タンパク質の翻訳後修飾の解析"", 現代化学 増刊４２ プロテオミクス−方法とその病態解析への応用−, 2002, ｐ．２４−３０ * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012524252A (ja) * | 2009-04-17 | 2012-10-11 | クイーン マリー アンド ウエストフィールド カレッジ | 修飾ペプチドの定量化方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2113562B1 (en) | 2012-02-15 |
| EP1780537A4 (en) | 2009-03-25 |
| JP2010133971A (ja) | 2010-06-17 |
| WO2006004214A1 (ja) | 2006-01-12 |
| EP2113562A1 (en) | 2009-11-04 |
| JP2011090012A (ja) | 2011-05-06 |
| US20080221802A1 (en) | 2008-09-11 |
| ATE525462T1 (de) | 2011-10-15 |
| ATE545460T1 (de) | 2012-03-15 |
| US8131479B2 (en) | 2012-03-06 |
| EP1780537B1 (en) | 2011-09-21 |
| EP1780537A1 (en) | 2007-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010133971A (ja) | リン酸化タンパク質のプロテオーム解析方法 | |
| Pagel et al. | Current strategies and findings in clinically relevant post-translational modification-specific proteomics | |
| JP4714584B2 (ja) | 同位体標識化内部標準物質を用いる定量方法、該定量方法を実行する解析システムおよび該解析のためのプログラム | |
| Pasing et al. | N-glycoproteomics: mass spectrometry-based glycosylation site annotation. | |
| Leitner et al. | Tools for analyzing the phosphoproteome and other phosphorylated biomolecules: a review | |
| Xu et al. | Mass spectrometry-intensive top-down proteomics: an update on technology advancements and biomedical applications | |
| Kolli et al. | Engaging challenges in glycoproteomics: recent advances in MS-based glycopeptide analysis | |
| Böhm et al. | Low-pH solid-phase amino labeling of complex peptide digests with TMTs improves peptide identification rates for multiplexed global phosphopeptide analysis | |
| Mayne et al. | Fine tuning of proteomic technologies to improve biological findings: advancements in 2011–2013 | |
| Chiou et al. | Clinical proteomics: current status, challenges, and future perspectives | |
| Magni et al. | Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry | |
| Zhu et al. | Single chain variable fragment displaying M13 phage library functionalized magnetic microsphere-based protein equalizer for human serum protein analysis | |
| Leitner et al. | Chemical tagging strategies for mass spectrometry-based phospho-proteomics | |
| Zhou et al. | Analysis of the subcellular phosphoproteome using a novel phosphoproteomic reactor | |
| Rosenqvist et al. | Analytical strategies in mass spectrometry-based phosphoproteomics | |
| King et al. | Enhanced sample multiplexing of tissues using combined precursor isotopic labeling and isobaric tagging (cPILOT) | |
| Wu et al. | Combining Alkaline Phosphatase Treatment and Hybrid Linear Ion Trap/Orbitrap High Mass Accuracy Liquid Chromatography− Mass Spectrometry Data for the Efficient and Confident Identification of Protein Phosphorylation | |
| Boccardi et al. | An automated plasma protein fractionation design: high-throughput perspectives for proteomic analysis | |
| Henry¹ et al. | and mass spectrometry | |
| Liu et al. | Integrated system for extraction, purification, and digestion of membrane proteins | |
| Mourino-Alvarez et al. | Aortic Stenosis: Studying Healthy Valves for a Better Understanding of the Disease | |
| Clive | Research Group Abstracts | |
| Clive | Roundtable Discussion Speaker Abstracts | |
| Clive | Scientific Session Speaker Abstracts | |
| Clive | Tutorial Session Speaker Abstracts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091201 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100129 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100413 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100614 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100928 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101228 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110201 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110222 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20110527 |